Taizo Yoshida

Taizo Yoshida

Auto-generated profile, based on publicly available information

Taizo Yoshida

Department of Surgery, Keiyu Hospital , 3-7-3 Minatomirai, Nishi-ku, Yokohama, Kanagawa 220-8521 , Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2020 in Open Heart
Verified
Journal Article
Open access
PDF file
TYTaizo Yoshida
Taizo Yoshida
SSSatoshi Shoji
Satoshi Shoji
YSYasuyuki Shiraishi
Yasuyuki Shiraishi
MKMasataka Kawana
Masataka Kawana
TKTakashi Kohno
Takashi Kohno
SKShun Kohsaka
Shun Kohsaka
Background Risk prediction for hospitalised heart failure (HF, HHF) patients remains suboptimal. We aimed to determine the prognostic value of hospital food intake (FI) immediately before discharge among HHF patients. Method We analysed the data of 255 HHF patients extracted from the records of a single university hospital. The FI percentage of the three meals the day before hospital discharge was averaged. Patients were stratified into adequate FI (100% consumption) and inadequate FI (less than 100% consumption) groups. The primary outcome was the composite of all-cause mortality and/or HF readmission within 1 year. Results Only 49.3% of HHF patients consumed 100% of their meals. Patients with inadequate FI were older; predominantly women; and had a lower body mass index, higher brain natriuretic peptide levels and Clinical Frailty Scale scores at discharge than those with adequate FI. Inadequate FI was significantly associated with adverse outcomes after adjustments (HR 2.00; 95% CI 1.09 to 3.67; p=0.026). The effect of interaction by ejection fraction (EF) was highly significant: HF with preserved EF (≥40%) was significantly associated with inadequate FI with adverse outcomes (HR 4.95; 95% CI 1.71 to 14.36; p=0.003) but HF with reduced EF (<40%) was not (HR 0.77; 95% CI 0.31 to 1.95; p=0.590). Conclusions The hospital FI assessment might be a simple, useful tool for predicting and stratifying risk for HHF patients.

5 December 2023 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
TYTaizo Yoshida
Taizo Yoshida
ASAkihiko Shimada
Akihiko Shimada
KMKoichi Matsumoto
Koichi Matsumoto
MIMichiko Inukai
Michiko Inukai
RHRyo Hashimoto
Ryo Hashimoto
HMHidetoshi Matsumoto
Hidetoshi Matsumoto
Metastasis to the gastrointestinal tract is rare. A 59-year-old woman who had a history of an invasive lobular carcinoma of breast with clinical complete response visited our hospital and complained of an upper abdominal pain and distension. We performed an upper gastrointestinal endoscopy which showed only a gastric ulcer without any malignant findings. She experienced a recurrence of symptoms 2 months after this visit. An endoscopy revealed pyloric stenosis, which did not improve with balloon dilatation. We performed a gastro-jejunal and cecal-transverse colonic bypass surgery. Diffuse wall thickening of the antrum was verified during the surgery, and a biopsy sample was collected. The diagnosis of gastric metastasis from breast was confirmed since it showed the same immunohistochemistry pattern as the prior breast lesion. Pyloric stenosis has still been confirmed with an endoscopy, she has been alive with satisfactory oral food intake for >10 years.

17 November 2025 in JTCVS Open
Verified
Journal Article
Open access
TYTaizo Yoshida
Taizo Yoshida
TSTomonari M. Shimoda
Tomonari M. Shimoda
YSYosuke Sakurai
Yosuke Sakurai
YYYujiro Yokoyama
Yujiro Yokoyama
SFShinichi Fukuhara
Shinichi Fukuhara
TKToshiki Kuno
Toshiki Kuno
The study evaluated whether no-touch saphenous vein harvesting (NTH) improves graft patency compared with conventional harvesting (CH) and whether this translates into clinical benefit in coronary artery bypass grafting. A systematic literature review was performed during May 2025 to retrieve randomized controlled trials comparing NTH and CH in coronary artery bypass grafting. Primary outcomes included graft occlusion per graft and per patient, and graft failure per patient. Secondary outcomes included all-cause death, myocardial infarction, repeat revascularization, recurrent angina, and leg wound complications. Data were extracted and pooled analyses were performed using a random-effects model. Ten randomized controlled trials with 4251 patients (NTH: 2143, CH: 2108) and 4848 grafts (NTH: 2415, CH: 2433) were included. Weighted mean follow-up was 39.0 months (range, 0.2-192 months). NTH was associated with a lower risk of graft occlusion per graft (risk ratio [RR], 0.70; 95% CI, 0.61-0.81), per patient (RR, 0.71; 95% CI, 0.60-0.84), and graft failure per patient (RR, 0.74; 95% CI, 0.64-0.87). Secondary outcomes showed no significant differences in all-cause death (hazard ratio [HR], 0.87; 95% CI, 0.43-1.79), myocardial infarction (HR, 0.79; 95% CI, 0.34-1.87), repeat revascularization (HR, 0.80; 95% CI, 0.32-1.95), and recurrent angina (HR, 0.59; 95% CI, 0.11-3.33), except for leg wound complications, which were significantly higher with NTH (RR, 1.78; 95% CI, 1.30-2.43). NTH significantly improves graft patency compared with CH but confers no midterm advantage in major clinical outcomes, with increased leg wound complications. Large-scale studies with extended follow-up are needed to define its clinical influence.